Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Diphenhydramine × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Neoplasm Metastasis 2 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Urinary Bladder Neoplasms 1 Pathologic Complete Response 1 Neoplasms 1 Carcinoma in Situ 1

Interventions

temsirolimus 1 pazopanib 1 Surveys and Questionnaires 1 Diphenhydramine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01392183 2021-09-20

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

M.D. Anderson Cancer Center

Phase 2 Completed

69 enrolled 15 charts

Pathologic Complete Response, Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡